Goldman Sachs’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
155,351
-432,069
| -74% | -$4.31M | ﹤0.01% | 3577 |
|
|
2025
Q1 | $3.51M | Sell |
587,420
-143,071
| -20% | -$854K | ﹤0.01% | 2985 |
|
|
2024
Q4 | $5.61M | Sell |
730,491
-182,522
| -20% | -$1.4M | ﹤0.01% | 2768 |
|
|
2024
Q3 | $9.32M | Buy |
913,013
+180,741
| +25% | +$1.85M | ﹤0.01% | 2319 |
|
|
2024
Q2 | $10.9M | Buy |
732,272
+16,015
| +2% | +$238K | ﹤0.01% | 2037 |
|
|
2024
Q1 | $9.77M | Sell |
716,257
-25,811
| -3% | -$352K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $8.13M | Buy |
742,068
+132,856
| +22% | +$1.45M | ﹤0.01% | 2238 |
|
|
2023
Q3 | $6.67M | Sell |
609,212
-34,453
| -5% | -$377K | ﹤0.01% | 2270 |
|
|
2023
Q2 | $8.52M | Buy |
643,665
+205,556
| +47% | +$2.72M | ﹤0.01% | 2157 |
|
|
2023
Q1 | $5.96M | Buy |
438,109
+11,598
| +3% | +$158K | ﹤0.01% | 2398 |
|
|
2022
Q4 | $8.33M | Buy |
426,511
+82,910
| +24% | +$1.62M | ﹤0.01% | 2259 |
|
|
2022
Q3 | $6.55M | Sell |
343,601
-67,470
| -16% | -$1.29M | ﹤0.01% | 2446 |
|
|
2022
Q2 | $8.47M | Buy |
411,071
+227,930
| +124% | +$4.7M | ﹤0.01% | 2267 |
|
|
2022
Q1 | $5.89M | Buy |
183,141
+65,837
| +56% | +$2.12M | ﹤0.01% | 2680 |
|
|
2021
Q4 | $5.46M | Sell |
117,304
-57,980
| -33% | -$2.7M | ﹤0.01% | 2728 |
|
|
2021
Q3 | $4.73M | Buy |
175,284
+54,010
| +45% | +$1.46M | ﹤0.01% | 2834 |
|
|
2021
Q2 | $3.11M | Buy |
121,274
+54,723
| +82% | +$1.4M | ﹤0.01% | 3150 |
|
|
2021
Q1 | $2.28M | Buy |
66,551
+5,892
| +10% | +$201K | ﹤0.01% | 3266 |
|
|
2020
Q4 | $2.05M | Buy |
60,659
+34,227
| +129% | +$1.16M | ﹤0.01% | 3057 |
|
|
2020
Q3 | $652K | Buy |
+26,432
| New | +$652K | ﹤0.01% | 3536 |
|